Multicenter registry study of Japanese patients with inflammatory bowel disease with COVID-19

Multicenter registry study of Japanese patients with inflammatory bowel disease with COVID-19 - Japan COVID-19 surveillance in inflammatory bowel disease (J-COSMOS)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040656

Enrollment

200

Registered

2020-08-01

Start date

2020-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease COVID-19

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inflammatory bowel disease patients with COVID-19 infection (ulcerative colitis, Crohn's disease, inflammatory bowel disease unclassified, intestinal Behcet's disease, simple ulcer)

Exclusion criteria

Exclusion criteria: Those who refused to participate in the study by opr-out

Design outcomes

Primary

Measure	Time frame
The rate of Japanese IBD patients with COVID-19	—

Secondary

Measure	Time frame
At the diagnosis of SARS-CoV-2 infection and COVID-19, treatment of IBD and the COVID-19 severity.	—

Countries

Japan

Contacts

Public ContactDAISUKE HIRAYAMA

Sapporo Medical University School of Medicine Department of Gastroenterology and Hepatology

hirarin95@yahoo.co.jp011-611-2111

Outcome results